Next Article in Journal
Developing a Vaccine Against Human Cytomegalovirus: Identifying and Targeting HCMV’s Immunological Achilles’ Heel
Previous Article in Journal
HPV Vaccine Delivery Strategies to Reach Out-of-School Girls in Low- and Middle-Income Countries: A Narrative Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Dors et al. Effect of Vaccination Against E. coli, C. perfringens Type A/C on Piglet Productive and Clinical Parameters Under Field Conditions. Vaccines 2024, 12, 1185

by
Arkadiusz Dors
1,*,
Robert Panek
2,
Wojciech Łużyński
3,
Krzysztof Janeczko
2,
Agata Augustyniak
1,
Hanna Turlewicz-Podbielska
1,
Ewelina Czyżewska-Dors
4 and
Małgorzata Pomorska-Mól
1,*
1
Department of Preclinical Sciences and Infectious Diseases, Faculty of Veterinary Medicine and Animal Science, Poznan University of Life Sciences, 60-637 Poznań, Poland
2
Ceva Animal Health, 03-715 Warsaw, Poland
3
Cedrob, 06-400 Ciechanów, Poland
4
Department of Internal Diseases and Diagnostics, Faculty of Veterinary Medicine and Animal Science, Poznan University of Life Sciences, 60-637 Poznań, Poland
*
Authors to whom correspondence should be addressed.
Vaccines 2025, 13(5), 434; https://doi.org/10.3390/vaccines13050434
Submission received: 20 March 2025 / Accepted: 7 April 2025 / Published: 22 April 2025
The authors would like to make the following corrections to this published paper [1].
The published article does not include mortality data. This may be confusing to some readers.
In the “Abstract” of the original publication, the sentence “The rest of the recorded parameters such as the presence of diarrhoea, the piglet’s body condition score, and the number of days with antimicrobial treatment did not differ significantly between groups” should be changed to “The rest of the recorded parameters such as the presence of diarrhoea, the piglet’s body condition score, the number of days with antimicrobial treatment, and preweaning mortality, did not differ significantly between groups”.
At the end of Section 2.3, “Evaluation of Production and Clinical Parameters”, a new paragraph has been added, which includes one sentence:
“Dead piglets were also recorded for those included in the experiment.”
At the end of Section 3.2, “Clinical Parameters”, a new paragraph has been added:
“Regarding mortality, no statistically significant differences were observed (Tables S1 and S2). Morality of piglets during the study period calculated as the sum of piglets excluded (BW at birth <800 g) and dead piglets to live born piglets was 19.0% (28/147) in group A and 12.2% (16/131) in group B (p = 0.119). Morality of piglets with BW at birth >800 g during the study period calculated as dead piglets to live born with BW > 800 g was 12.5% (17/136) in group A and 11.5% (15/130) in group B (p = 0.801).”
The authors would like to add two new tables (Tables S1 and S2) as Supplementary Materials:

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vaccines12101185/s1, Table S1. The number of piglets born and dead during the study period. Table S2. Morality of piglets during the study period.

Supplementary Materials

Table S1. The number of piglets born and dead during the study period.
Table S1. The number of piglets born and dead during the study period.
PigletsGroup AGroup B
Total born151135
Live born147131
Live born with BW > 800 g136130
Weighed at weaning119115
Stillborn44
Excluded (BW < 800 g)111
Dead (BW > 800 g)1715
BW—body weight at birth.
Table S2. Morality of piglets during the study period.
Table S2. Morality of piglets during the study period.
Different Morality Calculation MethodsGroup AGroup Bp-Value *
Stillborn+Excluded+Dead/Total born21.2% (32/151)14.8% (20/135)0.1627
Excluded+Dead/Live born19.0% (28/147)12.2% (16/131)0.1192
Dead/Live born11.6% (17/147)11.5% (15/131)0.9762
Dead/Live born with BW > 800 g12.5% (17/136)11.5% (15/130)0.8096
Dead/Weighed at weaning14.3% (17/119)13.0% (15/115)0.7821
*: The chi-square test of independence was applied.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Dors, A.; Panek, R.; Łużyński, W.; Janeczko, K.; Augustyniak, A.; Turlewicz-Podbielska, H.; Czyżewska-Dors, E.; Pomorska-Mól, M. Effect of Vaccination Against E. coli, C. perfringens Type A/C on Piglet Productive and Clinical Parameters Under Field Conditions. Vaccines 2024, 12, 1185. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Dors, A.; Panek, R.; Łużyński, W.; Janeczko, K.; Augustyniak, A.; Turlewicz-Podbielska, H.; Czyżewska-Dors, E.; Pomorska-Mól, M. Correction: Dors et al. Effect of Vaccination Against E. coli, C. perfringens Type A/C on Piglet Productive and Clinical Parameters Under Field Conditions. Vaccines 2024, 12, 1185. Vaccines 2025, 13, 434. https://doi.org/10.3390/vaccines13050434

AMA Style

Dors A, Panek R, Łużyński W, Janeczko K, Augustyniak A, Turlewicz-Podbielska H, Czyżewska-Dors E, Pomorska-Mól M. Correction: Dors et al. Effect of Vaccination Against E. coli, C. perfringens Type A/C on Piglet Productive and Clinical Parameters Under Field Conditions. Vaccines 2024, 12, 1185. Vaccines. 2025; 13(5):434. https://doi.org/10.3390/vaccines13050434

Chicago/Turabian Style

Dors, Arkadiusz, Robert Panek, Wojciech Łużyński, Krzysztof Janeczko, Agata Augustyniak, Hanna Turlewicz-Podbielska, Ewelina Czyżewska-Dors, and Małgorzata Pomorska-Mól. 2025. "Correction: Dors et al. Effect of Vaccination Against E. coli, C. perfringens Type A/C on Piglet Productive and Clinical Parameters Under Field Conditions. Vaccines 2024, 12, 1185" Vaccines 13, no. 5: 434. https://doi.org/10.3390/vaccines13050434

APA Style

Dors, A., Panek, R., Łużyński, W., Janeczko, K., Augustyniak, A., Turlewicz-Podbielska, H., Czyżewska-Dors, E., & Pomorska-Mól, M. (2025). Correction: Dors et al. Effect of Vaccination Against E. coli, C. perfringens Type A/C on Piglet Productive and Clinical Parameters Under Field Conditions. Vaccines 2024, 12, 1185. Vaccines, 13(5), 434. https://doi.org/10.3390/vaccines13050434

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop